Literature DB >> 10466801

Expression in cattle of epitopes of a heterologous virus using a recombinant rinderpest virus.

Michael D Baron1, Mildred Foster-Cuevas1, Jana Baron1, Thomas Barrett1.   

Abstract

We have investigated the bovine immune response to heterologous proteins expressed using a recombinant rinderpest virus (RPV). A new gene unit was created in a cDNA copy of the genome of the vaccine strain of RPV, and an open reading frame inserted that encodes the polymerase (3Dpol) and parts of the capsid protein VP1 from foot-and-mouth disease virus (FMDV). Infectious recombinant RPV was rescued and shown to express the FMDV-derived protein at good levels in infected cells. The rescued virus was only slightly more attenuated in tissue culture than the original virus. Cattle infected with this recombinant generated a normal immune response to RPV, and were protected from lethal challenge by that virus. Experimental animals showed a specific delayed-type hypersensitivity response to FMDV 3Dpol, similar to that seen in FMDV infection; however, no antibodies were detected recognizing either of the components of the FMDV-derived protein, nor was any proliferative response to these epitopes found in isolated peripheral blood lymphocytes from infected animals. No protection was seen against FMDV infection.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10466801     DOI: 10.1099/0022-1317-80-8-2031

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  13 in total

1.  Recombinant rinderpest vaccines expressing membrane-anchored proteins as genetic markers: evidence of exclusion of marker protein from the virus envelope.

Authors:  E P Walsh; M D Baron; L F Rennie; P Monaghan; J Anderson; T Barrett
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

2.  Rinderpest viruses lacking the C and V proteins show specific defects in growth and transcription of viral RNAs.

Authors:  M D Baron; T Barrett
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

3.  Recombinant Newcastle disease virus as a vaccine vector.

Authors:  T Nakaya; J Cros; M S Park; Y Nakaya; H Zheng; A Sagrera; E Villar; A García-Sastre; P Palese
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

4.  Establishment of a Nipah virus rescue system.

Authors:  Misako Yoneda; Vanessa Guillaume; Fusako Ikeda; Yuki Sakuma; Hiroki Sato; T Fabian Wild; Chieko Kai
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-19       Impact factor: 11.205

5.  Recovery and characterization of a chimeric rinderpest virus with the glycoproteins of peste-des-petits-ruminants virus: homologous F and H proteins are required for virus viability.

Authors:  S C Das; M D Baron; T Barrett
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

6.  Reverse genetics with a full-length infectious cDNA of severe acute respiratory syndrome coronavirus.

Authors:  Boyd Yount; Kristopher M Curtis; Elizabeth A Fritz; Lisa E Hensley; Peter B Jahrling; Erik Prentice; Mark R Denison; Thomas W Geisbert; Ralph S Baric
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-20       Impact factor: 11.205

7.  Rescue of recombinant peste des petits ruminants virus: creation of a GFP-expressing virus and application in rapid virus neutralization test.

Authors:  Qianqian Hu; Weiye Chen; Kehe Huang; Michael D Baron; Zhigao Bu
Journal:  Vet Res       Date:  2012-06-02       Impact factor: 3.683

8.  A novel recombinant Peste des petits ruminants-canine adenovirus vaccine elicits long-lasting neutralizing antibody response against PPR in goats.

Authors:  Junling Qin; Hainan Huang; Yang Ruan; Xiaoqiang Hou; Songtao Yang; Chengyu Wang; Geng Huang; Tiecheng Wang; Na Feng; Yuwei Gao; Xianzhu Xia
Journal:  PLoS One       Date:  2012-05-18       Impact factor: 3.240

9.  Creation of a completely helper cell-dependent recombinant morbillivirus.

Authors:  Jana Baron; Michael Baron
Journal:  J Gen Virol       Date:  2013-02-20       Impact factor: 3.891

10.  Induction of protective immune response against both PPRV and FMDV by a novel recombinant PPRV expressing FMDV VP1.

Authors:  Chunsheng Yin; Weiye Chen; Qianqian Hu; Zhiyuan Wen; Xijun Wang; Jinying Ge; Qianqian Yin; Haibing Zhi; Chun Xia; Zhigao Bu
Journal:  Vet Res       Date:  2014-06-04       Impact factor: 3.683

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.